170 related articles for article (PubMed ID: 8819551)
21. Myasthenia gravis in childhood.
Gamio S; Garcia-Erro M; Vaccarezza MM; Minella JA
Binocul Vis Strabismus Q; 2004; 19(4):223-31. PubMed ID: 15530139
[TBL] [Abstract][Full Text] [Related]
22. [Clinical characteristics and follow-up management of 135 children with myasthenia gravis].
Yang ZX; Xiong H; Zhang YH; Bao XH; Jiang YW; Wu Y; Wang S; Chang XZ; Qin J; Lin Q; Wu XR
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):455-9. PubMed ID: 21681282
[TBL] [Abstract][Full Text] [Related]
23. Long remission in muscle-specific kinase antibody-positive juvenile myasthenia.
Anlar B; Yilmaz V; Saruhan-Direskeneli G
Pediatr Neurol; 2009 Jun; 40(6):455-6. PubMed ID: 19433280
[TBL] [Abstract][Full Text] [Related]
24. High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis.
Yapici Z; Tüzün E; Altunayoğlu V; Erdoğan A; Eraksoy M
Int J Neurosci; 2007 Nov; 117(11):1505-12. PubMed ID: 17917921
[TBL] [Abstract][Full Text] [Related]
25. Myasthenia gravis in Hong Kong Chinese. 2. Paediatric disease.
Wong V; Hawkins BR; Yu YL
Acta Neurol Scand; 1992 Jul; 86(1):68-72. PubMed ID: 1519477
[TBL] [Abstract][Full Text] [Related]
26. The Clinical Course and Treatment of a Case of Refractory Systemic Juvenile Myasthenia Gravis Successfully Treated with Thymectomy.
Shibuya M; Shichiji M; Ikeda M; Kodama K; Miyabayashi T; Sato R; Okubo Y; Endo W; Inui T; Togashi N; Nagao M; Sato K; Sato T; Kanzaki M; Segawa O; Masui K; Ishigaki K; Haginoya K
Tohoku J Exp Med; 2024 Jan; 262(1):29-31. PubMed ID: 37967941
[TBL] [Abstract][Full Text] [Related]
27. Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis.
Andrews PI; Massey JM; Howard JF; Sanders DB
Neurology; 1994 Jul; 44(7):1208-14. PubMed ID: 8035917
[TBL] [Abstract][Full Text] [Related]
28. [Myasthenia gravis in children: clinical study of 77 patients].
Zhou SZ; Li WH; Sun DK
Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):256-9. PubMed ID: 15157383
[TBL] [Abstract][Full Text] [Related]
29. Management of Juvenile Myasthenia Gravis.
O'Connell K; Ramdas S; Palace J
Front Neurol; 2020; 11():743. PubMed ID: 32793107
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of pediatric myasthenia: a surveillance study.
VanderPluym J; Vajsar J; Jacob FD; Mah JK; Grenier D; Kolski H
Pediatrics; 2013 Oct; 132(4):e939-44. PubMed ID: 24019417
[TBL] [Abstract][Full Text] [Related]
31. Genetic, serological and clinical evaluation of childhood myasthenia syndromes- single center subgroup analysis experience in Turkey.
Özsoy Ö; Cinleti T; Günay Ç; Sarıkaya Uzan G; Giray Bozkaya Ö; Çağlayan AO; Hız Kurul S; Yiş U
Acta Neurol Belg; 2023 Dec; 123(6):2325-2335. PubMed ID: 37656362
[TBL] [Abstract][Full Text] [Related]
32. An increase in circulating B cell-activating factor in childhood-onset ocular myasthenia gravis.
Motobayashi M; Inaba Y; Nishimura T; Kobayashi N; Nakazawa Y; Koike K
Pediatr Neurol; 2015 Apr; 52(4):404-9. PubMed ID: 25661289
[TBL] [Abstract][Full Text] [Related]
33. [Juvenile myasthenia gravis in sub-Saharan Africa: a case study of two consanguine sisters born from consanguinity in Togo].
Maneh N; Apetse K; Diatewa BM; Domingo SA; Agba AI; Ayena KD; Balogou KA; Balo KP
Pan Afr Med J; 2017; 28():63. PubMed ID: 29230265
[TBL] [Abstract][Full Text] [Related]
34. Clinical features of myasthenia gravis in southern China: a retrospective review of 2,154 cases over 22 years.
Huang X; Liu WB; Men LN; Feng HY; Li Y; Luo CM; Qiu L
Neurol Sci; 2013 Jun; 34(6):911-7. PubMed ID: 22806326
[TBL] [Abstract][Full Text] [Related]
35. Three cases of myasthenia gravis from one family with variations in clinical features and serum antibodies.
Chen Y; Wang W; Wei D; Yang L
Neuromuscul Disord; 2012 Mar; 22(3):286-8. PubMed ID: 22082588
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune myasthenia gravis.
Jayawant S; Parr J; Vincent A
Handb Clin Neurol; 2013; 113():1465-8. PubMed ID: 23622368
[TBL] [Abstract][Full Text] [Related]
37. ["Seronegative" myasthenia with antibodies against muscle-specific tyrosine-kinase].
Hain B; Hanisch F; Deschauer M
Nervenarzt; 2004 Apr; 75(4):362-7. PubMed ID: 15042294
[TBL] [Abstract][Full Text] [Related]
38. Developing outcome measures of disease activity in pediatric myasthenia.
Prior DE; Cooper BA; Zhang B; Ghosh PS
Muscle Nerve; 2021 May; 63(5):751-757. PubMed ID: 33604899
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous remission in juvenile myasthenia gravis: A cohort of 13 cases and review of the literature.
Arroyo HA; Torres AR
Neuromuscul Disord; 2022 Mar; 32(3):213-219. PubMed ID: 35094888
[TBL] [Abstract][Full Text] [Related]
40. Myasthenia gravis in children: a longitudinal study.
Ashraf VV; Taly AB; Veerendrakumar M; Rao S
Acta Neurol Scand; 2006 Aug; 114(2):119-23. PubMed ID: 16867035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
